One potential explanation for its selective therapeutic efficacy and induction of differentiation may be the specific dependency of FOXO1 and FOXO3 in AML, as evidenced by their elevated expression levels in these cells (Supplementary Fig. 5A). Here, FOXO1 is linked to acute myeloid leukemia.